Sientra to Present at the SVB Leerink 10th Annual Global Healthcare Conference

Rhea-AI Summary

Sientra, a medical aesthetics company focused on plastic surgeons, will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021, at 3:40 p.m. ET. The presentation will be available via audio webcast on Sientra's investor relations website, with a replay accessible for 90 days. Sientra offers innovative products, including FDA-approved breast implants and the miraDry system for sweat reduction, aimed at enhancing patients' body image and confidence.

SANTA BARBARA, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the company will be participating in the upcoming SVB Leerink 10^th Annual Global Healthcare Conference. Sientra’s management team is scheduled to present on Friday, February 26, 2021 at 3:40 p.m. ET.

Event: SVB Leerink 10^th Annual Global Healthcare Conference
Date: Friday, February 26, 2021
Time: 3:40 p.m. ET
                          
An audio webcast of the Company’s presentation will be made available on the investor relations section of Sientra’s website at http://www.sientra.com. A replay will be available for 90 days.

About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company uniquely focused on plastic surgeons. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2^® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM^®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprised of its miraDry^® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.
^(*) Data on file

Contact
Investor Relations
805-679-8885

FAQ

When is Sientra's presentation at the SVB Leerink 10th Annual Global Healthcare Conference?

Sientra will present on February 26, 2021, at 3:40 p.m. ET.

Where can I listen to Sientra's presentation?

The presentation will be available via an audio webcast on Sientra's investor relations website.

What products does Sientra offer?

Sientra offers FDA-approved breast implants and the miraDry system for permanent sweat reduction.

How long will the replay of Sientra’s presentation be available?

The replay of the presentation will be accessible for 90 days.

What is the focus of Sientra, Inc.?

Sientra is focused on medical aesthetics, particularly products for plastic surgeons.